|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 1,626 SEK | -0,55% |
|
-4,35% | -66,16% |
| 17/06 | Oncopeptides AB (publ) annonce le recrutement du premier patient dans son étude sur le glioblastome | CI |
| 15/06 | GSA Capital devient un nouveau vendeur à découvert déclaré chez Oncopeptides | FW |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0,55% | -4,35% | -3,73% | -3,90% | -66,16% | +12,45% | -80,92% | -98,19% | - | 68,76 M | ||
| -2,23% | -0,03% | +10,04% | +23,83% | +6,42% | +61,34% | +109,10% | +187,20% | +6 614,79% | 56,24 Md | ||
| +4,60% | +5,85% | -0,40% | +11,10% | +13,33% | +54,47% | +43,04% | -24,47% | - | 43,76 Md | ||
| -1,44% | +5,50% | +1,50% | -4,19% | -4,53% | -13,41% | -19,24% | -57,57% | - | 23,32 Md | ||
| -2,69% | +4,27% | -12,22% | -33,44% | -44,96% | -4,47% | +379,00% | +227,75% | +912,68% | 21,34 Md | ||
| +3,22% | +3,77% | -8,49% | -11,79% | -1,97% | +19,92% | -35,05% | -74,49% | - | 15,75 Md | ||
| -0,67% | +1,18% | -3,38% | -5,02% | -19,73% | +12,91% | -39,22% | -40,34% | +48,31% | 15,6 Md | ||
| -1,01% | -1,27% | +3,55% | +24,10% | +18,43% | +25,52% | +171,92% | +134,57% | +583,03% | 13,18 Md | ||
| +3,07% | +3,59% | -4,76% | -1,33% | +6,02% | +25,54% | - | - | - | 12,01 Md | ||
| +4,95% | +7,51% | +28,33% | +61,34% | +125,53% | +123,21% | +249,05% | +1 184,19% | +427,52% | 11,87 Md | ||
| +1,18% | +7,31% | -3,43% | +14,12% | -13,15% | +80,88% | +107,20% | +381,30% | - | 11,52 Md | ||
| +0,96% | +15,68% | +6,72% | +42,12% | +23,24% | +427,87% | +131,13% | -4,84% | +1 325,44% | 11,42 Md | ||
| -2,27% | +5,36% | -18,49% | -13,25% | -21,38% | -30,73% | +561,06% | +106,15% | +69,97% | 10,92 Md | ||
| +0,86% | +17,46% | +3,86% | +26,80% | +23,98% | +142,10% | +126,12% | +259,07% | +756,30% | 10,61 Md | ||
| +4,35% | -0,45% | -27,16% | -25,49% | -22,52% | -6,91% | +133,78% | +46,65% | - | 9,86 Md | ||
| +0,06% | +0,06% | +20,65% | +24,71% | +22,71% | +62,28% | +185,32% | - | - | 9,75 Md | ||
| +0,74% | -.--% | -.--% | -.--% | -.--% | -.--% | +32,20% | +230,83% | - | 8,19 Md | ||
| 0,00% | +8,23% | -10,55% | -13,62% | -38,96% | - | - | - | - | 7,45 Md | ||
| +1,63% | -2,14% | -23,34% | -24,93% | -4,86% | +36,18% | +86,14% | -45,20% | - | 7,5 Md | ||
| +0,97% | +17,66% | +17,91% | +101,00% | +169,66% | +481,95% | +2 429,42% | -45,89% | -20,77% | 7,6 Md | ||
| Moyenne | +0,79% | +4,24% | -1,17% | +9,61% | +8,55% | +79,53% | +253,89% | +139,22% | +1 190,81% | 15,4 Md | |
| Moyenne pondérée par Capi. | +0,60% | +4,27% | +0,50% | +9,84% | +7,92% | +64,91% | +181,64% | +132,41% | +2 700,56% |
- Bourse
- Actions
- Action ONCO
- Secteur Oncopeptides AB
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
















